Clinical trial
A Randomized Controlled Study of Cytokine-induced Killer Cells (CIK) Treatment in Patients With Staging Ⅰ-Ⅲ of Urinary Bladder Carcinoma
NCT02489890 is registered in ClinicalTrials.gov with The First People's Hospital of Changzhou as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Study of Cytokine-induced Killer Cells (CIK) Treatment in Patients With Staging Ⅰ-Ⅲ of Urinary Bladder Carcinoma
- Lead sponsor
- The First People's Hospital of Changzhou
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- February 29, 2016
- Completion date
- July 31, 2030
- Enrollment
- 1,500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.